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BAPCAP2-1 
Does preoperative aspirin improve outcomes in cardiac 
surgery patients? 
 
Sun J., Cao L., Liu H., Sun W., Silvestry S., Diehl J. 
Thomas Jefferson Universit y, Department of Anaesthesiology, Philadelphia, 
United States 
 
Background and Goal of Study: The ef fects of preoperative aspirin on major 
cardiocerebral and renal outcomes and mortality remain uncertain. 
 
Results and Discussion: Of all patients, 2868 patients met the inclusion criteria 
and were divided into two groups: those taking (n=1923) or not taking 
(n=945) aspirin within 5 days preceding surgery. The groups did not dif fer 
significantly in baseline parameters including body mass index, smoking, 
congestive heart failure and intra-operative cross-clamping time. Patients in 
the aspirin group had significantly more with history of hypertension, diabetes, 
peripheral arterial disease, previous MI, angina, cerebrovascular disease, 
chronic lung disease, older age and male gender; also were associated with 
more preoperative using beta-blockers and rennin-angiotensin system inhibitors, 
and more lef t main and multiple coronary artery disease, but spent less 
time in bypass perfusion. With propensity scores adjusted and multivariate logistic 
regression, however, the results of this study showed that preoperative 
use of aspirin significantly reduced the incidence of MACE (8.7% incidence 
in the aspirin group vs. 10.8% in the non-aspirin group, adjusted odds ratio 
[OR]: 0.662, 95% confidence interval [CI]: 0.482-0.909, P=0.011), postoperative 
renal failure (3.7% vs. 7.1%, OR 0.384, 95% CI 0.254-0.579, P< 0.001), 
and 30-day mortality (3.5% vs. 6.5%, OR 0.611, 95% CI 0.391-0.956, P=0.031) 
in the patients undergoing cardiac surgery. 
 
However, 30-day readmission and intensive care unit stay did not show a significant 
dif ference between two groups. 
 
Conclusion(s): The results of this study showed that preoperative therapy of 
aspirin significantly reduced major cardiocerebral complications, renal failure 
and 30-day mortality in patients undergoing cardiac surgery. 
